Sign Out
Treatment should be avoided if the joint shows evidence of acute inflammation.
The safety and efficacy of HYMOVIS in children and pregnant women have not been established.
The safety and efficacy of the use of HYMOVIS concomitantly with other intra-articular treatments have not been established.
The syringe is intended for single use; inject the contents in one joint only.
If this product is reprocessed and/or reused, Fidia Farmaceutici cannot guarantee performance, functionality, material structure, or cleanliness or sterility of the product. Reuse could lead to illness, infection and/or serious injury to the patient or user.
Do not use HYMOVIS if the package is opened or damaged.
